Kingsview Wealth Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $107K | Hold |
12,120
| – | – | ﹤0.01% | 1138 |
|
2025
Q1 | $90.8K | Hold |
12,120
| – | – | ﹤0.01% | 1066 |
|
2024
Q4 | $101K | Hold |
12,120
| – | – | ﹤0.01% | 1080 |
|
2024
Q3 | $84.1K | Hold |
12,120
| – | – | ﹤0.01% | 1072 |
|
2024
Q2 | $59.4K | Hold |
12,120
| – | – | ﹤0.01% | 1024 |
|
2024
Q1 | $70.3K | Hold |
12,120
| – | – | ﹤0.01% | 1000 |
|
2023
Q4 | $79.4K | Hold |
12,120
| – | – | ﹤0.01% | 932 |
|
2023
Q3 | $58.4K | Hold |
12,120
| – | – | ﹤0.01% | 922 |
|
2023
Q2 | $61.8K | Hold |
12,120
| – | – | ﹤0.01% | 890 |
|
2023
Q1 | $66.7K | Hold |
12,120
| – | – | ﹤0.01% | 864 |
|
2022
Q4 | $55.6K | Hold |
12,120
| – | – | ﹤0.01% | 826 |
|
2022
Q3 | $76K | Hold |
12,120
| – | – | ﹤0.01% | 797 |
|
2022
Q2 | $54K | Hold |
12,120
| – | – | ﹤0.01% | 799 |
|
2022
Q1 | $61K | Sell |
12,120
-190
| -2% | -$956 | ﹤0.01% | 842 |
|
2021
Q4 | $107K | Hold |
12,310
| – | – | ﹤0.01% | 867 |
|
2021
Q3 | $115K | Hold |
12,310
| – | – | 0.01% | 816 |
|
2021
Q2 | $164K | Hold |
12,310
| – | – | 0.01% | 835 |
|
2021
Q1 | $117K | Buy |
+12,310
| New | +$117K | 0.01% | 789 |
|